Want to see FR:ALTUV full AI Analyst Report?
Top Page
Bio-UV Group SA
(ALTUV)
Select Model
Select Model
Rating:57Neutral
Price Target:
€1.50
▼(-5.06% Downside)
Action:Reiterated
Date:05/09/26
The score is mainly supported by comparatively stronger cash generation and a reasonably stable balance sheet, but capped by declining revenue and inconsistent profitability. Technical indicators are largely neutral-to-soft (flat moving averages, slightly negative MACD, low stochastic), and valuation is difficult to justify using a negative P/E with no dividend yield provided.
Positive Factors
Cash generation
Consistent positive operating cash flow and accelerating free cash flow in 2025 improve financial flexibility. Durable cash conversion supports reinvestment in product development, funds working capital for project execution, and reduces dependence on external financing during cyclical revenue periods.
Negative Factors
Declining revenue trend
Sustained revenue declines from 2023–2025 limit operating leverage and constrain the company's ability to scale fixed-cost investments. Lower top-line pressure reduces margin expansion potential, weakens negotiating power with suppliers, and makes consistent earnings recovery harder without market share gains.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash generation
Consistent positive operating cash flow and accelerating free cash flow in 2025 improve financial flexibility. Durable cash conversion supports reinvestment in product development, funds working capital for project execution, and reduces dependence on external financing during cyclical revenue periods.
Read all positive factors
Bio-UV Group SA (ALTUV) vs. iShares MSCI France ETF (EWQ)
Market Cap
€18.14M
Dividend YieldN/A
Average Volume (3M)11.56K
Price to Earnings (P/E)22.6
Beta (1Y)0.23
Revenue Growth-9.27%
EPS Growth1858.06%
CountryFR
Employees155
SectorIndustrials
Sector Strength72
IndustryWaste Management
Share Statistics
EPS (TTM)0.06
Shares Outstanding14,154,679
10 Day Avg. Volume12,225
30 Day Avg. Volume11,557
Financial Highlights & Ratios
PEG Ratio0.01
Price to Book (P/B)0.52
Price to Sales (P/S)0.58
P/FCF Ratio6.99
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.09
Revenue Forecast (FY)€38.50M
Bio-UV Group SA Business Overview & Revenue Model
Company Description
Based in Lunel, France, BIO-UV Group S.A. specializes in the conception, production, and commercialization of ultraviolet (UV) light systems for the purification of water and disinfection of surfaces. Serving both private individuals and professio...
How the Company Makes Money
Bio-UV Group makes money primarily by selling water-treatment equipment, especially UV disinfection systems, to customers in its target end-markets. Its revenue model typically includes (1) product sales of UV reactors and complete treatment units...
Bio-UV Group SA Financial Statement Overview
Summary
Income Statement
52
Neutral
Balance Sheet
63
Positive
Cash Flow
72
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 35.90M | 39.58M | 43.13M | 51.29M | 33.46M |
| Gross Profit | 2.00M | 24.09M | 25.58M | 4.71M | 1.84M |
| EBITDA | 1.60M | 4.18M | 4.43M | 6.38M | 3.35M |
| Net Income | 836.34K | 31.36K | 124.89K | 2.42M | 689.38K |
Balance Sheet | |||||
| Total Assets | 69.21M | 66.09M | 71.41M | 74.08M | 81.12M |
| Cash, Cash Equivalents and Short-Term Investments | 10.18M | 3.87M | 2.73M | 1.98M | 10.57M |
| Total Debt | 20.23M | 23.99M | 28.27M | 29.15M | 30.74M |
| Total Liabilities | 28.68M | 33.40M | 39.19M | 41.74M | 50.43M |
| Stockholders Equity | 40.47M | 32.69M | 32.22M | 32.24M | 30.52M |
Cash Flow | |||||
| Free Cash Flow | 3.00M | 5.00M | 4.28M | 476.03K | 571.69K |
| Operating Cash Flow | 4.63M | 6.90M | 6.24M | 2.70M | 3.30M |
| Investing Cash Flow | -1.60M | -1.87M | -1.95M | -8.95M | -20.70M |
| Financing Cash Flow | 3.37M | -3.73M | -3.57M | -2.50M | 15.53M |
Bio-UV Group SA Technical Analysis
Negative
1.58
Price Trends
1.37
Negative
1.35
Negative
1.45
Negative
Market Momentum
-0.01
Positive
44.54
Neutral
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALTUV, the sentiment is Negative. The current price of 1.58 is above the 20-day moving average (MA) of 1.36, above the 50-day MA of 1.37, and above the 200-day MA of 1.45, indicating a bearish trend. The MACD of -0.01 indicates Positive momentum. The RSI at 44.54 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALTUV.
Bio-UV Group SA Peers Comparison
UnderperformOutperform
Sector (63)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
64 Neutral | €1.53B | 11.60 | 11.12% | 1.90% | -2.88% | 24.77% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | €26.71B | 21.98 | 15.69% | 4.77% | -0.66% | 9.47% | |
58 Neutral | €604.53M | 27.98 | 12.51% | 1.69% | 5.24% | -39.46% | |
57 Neutral | €18.14M | 22.58 | ― | ― | -9.27% | 1858.06% | |
42 Neutral | €15.76M | -1.35 | 22.45% | ― | ― | ― |
* Industrials Sector Average
FR:ALTUV
Bio-UV Group SA
1.33
-0.57
-30.00%
FR:DBG
Derichebourg
9.63
3.94
69.25%
FR:SCHP
Seche Environnement
77.50
-23.73
-23.44%
FR:VIE
Veolia Environnement
36.49
7.30
24.99%
FR:OREGE
Orege SA
0.31
0.02
7.96%
FR:GPE
Groupe Pizzorno Environnement SA
62.20
4.54
7.87%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.